Norman Sharpless - Jul 22, 2022 Form 3 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Jul 22, 2022
Transactions value $
$0
Form type
3
Date filed
8/2/2022, 06:44 PM
Next filing
Aug 5, 2022

No securities are beneficially owned.